Back to results
US 2025/0144046 A1Published application
Pharmaceutical compositions and methods of administration
AssigneeMetastx, LLC
InventorsDavid CRICH, Somanath SHENOY, Brian CUMMINGS, Harvey D. HOMAN, Daniel A. GESELOWITZ
Life of this patent
Estimating the term…
Abstract
The present disclosure describes novel compounds and compositions and methods of making and using thereof related that are capable of inhibiting PAK1 and associated diseases or disorders, including tumors and cancerous cells. The inventive compounds are more efficacious and stable than IPA-3 without needing liposomal formulations as vehicles for the compounds.
Claims14
A compound having the structure:
- or a pharmaceutically acceptable salt thereof,
- wherein W and V are each independently H or OH;
- wherein X and Y are each independently an attachment site, methine, methylene, N, N-alkyl, N-acyl, N-sulfonyl, O, S, CO, or SO2, with the provisos that X and Y cannot both be an attachment site, O, S, or SO2 and that if X or Y is methine, X and Y are both methines to form a double bond;
- wherein the alkyl group of the N-alkyl and N-acyl groups is a C1-C6 alkyl group that is linear or branched, unsubstituted or substituted, with one or more substitutions selected from the group consisting of hydroxyl groups, halogens, cyano groups, amines, and mixtures thereof;
- and
- wherein Z is CHR where R is H or C1-C6 alkyl, wherein the C1-C6 alkyl group of Z is linear or branched, unsubstituted or substituted, with one or more substitutions selected from the group consisting of hydroxyl groups, halogens, cyano groups, amines, and mixtures thereof.
3 more elements
Dependencies are inferred from the claim text.